Effects of early spasticity treatment on children with hemiplegic cerebral palsy: a preliminary study

被引：6

作者：

Zonta, Marise Bueno ^{[1
]}

Bruck, Isac ^{[2
]}

Puppi, Marilene ^{[3
]}

Muzzolon, Sandra ^{[4
]}

de Carvalho Neto, Arnolfo ^{[5
]}

Coutinho dos Santos, Lucia Helena ^{[2
]}

机构：

[1] Univ Fed Parana, UFPR, Clin Hosp, Neuropediat Ctr, BR-80060000 Curitiba, Parana, Brazil

[2] UFPR, Dept Pediat, Curitiba, Parana, Brazil

[3] UFPR, Neuropediat Ctr, Curitiba, Parana, Brazil

[4] UFPR, Neuropediat Ctr, Clin Hosp, Curitiba, Parana, Brazil

[5] UFPR, Dept Internal Med, Curitiba, Parana, Brazil

来源：

ARQUIVOS DE NEURO-PSIQUIATRIA | 2013年 / 71卷 / 07期

关键词：

child; botulinum toxins; type A; cerebral palsy; hemiplegia; TOXIN TYPE-A; GROSS MOTOR FUNCTION; BOTULINUM-TOXIN; UPPER-LIMB; MANAGEMENT;

D O I：

10.1590/0004-282X20130061

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Objective: To compare motor and functional performance of two groups of children with hemiplegic cerebral palsy (HOP). Only the study group (SG) received early treatment of spasticity with botulinum neurotoxin type A (BXT-A). Methods: Gross Motor Function Measure (GM FM), functional performance (Pediatric Evaluation of Disability Inventory - PEDI), range of movement, gait pattern (Physician Rating Scale - PRS) and the speed of hand movements were considered. Results: The SG, composed of 11 HOP (45.64 +/- 6.3 months), was assessed in relation to the comparison group, composed of 13 HOP (45.92 +/- 6.4 months). SG showed higher scores in four of the five GMFM dimensions, which included scores that were statistically significant for dimension B, and higher scores in five of the six areas evaluated in the PEDI. Active wrist extension, the speed of hand movements and PRS score were higher in the SG. Conclusion: Children who received early BXT-A treatment for spasticity showed higher scores in motor and functional performance.

引用

页码：453 / 461

页数：9

共 30 条

[1] Functional therapy for children with cerebral palsy: an ecological approach [J].

Ahl, LE ;

Johansson, E ;

Granat, T ;

Carlberg, EB .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2005, 47 (09) :613-619

[2]

ASHWORTH B, 1964, PRACTITIONER, V192, P540

[3] Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury:: clinical implications [J].

Autti-Rämö, I ;

Larsen, A ;

Taimo, A ;

von Wendt, L .

EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 :136-144

[4] The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years [J].

Beckung, E. ;

Carlsson, G. ;

Carlsdotter, S. ;

Uvebrant, P. .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2007, 49 (10) :751-756

[5] Probability of walking in children with cerebral palsy in Europe [J].

Beckung, Eva ;

Hagberg, Gudrun ;

Uldall, Peter ;

Cans, Christine .

PEDIATRICS, 2008, 121 (01) :E187-E192

[6] Botulinum toxin for spasticity in children with cerebral palsy: A comprehensive evaluation [J].

Bjornson, Kristie ;

Hays, Ross ;

Graubert, Cathy ;

Price, Robert ;

Won, Francine ;

McLaughlin, John F. ;

Cohen, Morty .

PEDIATRICS, 2007, 120 (01) :49-58

[7]

BLECK EE, 1975, DEV MED CHILD NEUROL, V17, P18

[8] Management of upper limb dysfunction in children with cerebral palsy: a systematic review [J].

Boyd, RN ;

Morris, ME ;

Graham, HK .

EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 :150-166

[9] Effective Results With Botulinum Toxin in Cerebral Palsy [J].

Coutinho dos Santos, Lucia H. ;

Bufara Rodrigues, Danielle Caldas ;

Simoes de Assis, Taisa R. ;

Bruck, Isac .

PEDIATRIC NEUROLOGY, 2011, 44 (05) :357-363

[10] A preliminary report of the use of botulinum toxin type A in infants with clubfoot: Four case studies [J].

Delgado, MR ;

Wilson, H ;

Johnston, T ;

Richards, S ;

Karol, L .

JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2000, 20 (04) :533-538

← 1 2 3 →